|
Insider Trading: Omrix Biopharmaceuticals, Inc.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omrix Biopharmaceuticals, Inc. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Omrix Biopharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Omrix Biopharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is OMRI.
The reporting company's CIK number is 1349426.
The total value of stock buying since 2005 is $1,500,186.
The total value of stock sales is $34,613,934.
The total value of stock exercises is $1,904,651.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Omrix Biopharmaceuticals, Inc. (OMRI) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at Omrix Biopharmaceuticals, Inc. (OMRI) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Omrix Biopharmaceuticals, Inc. (OMRI).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-03 | 117,990 | 1,461,176 | 0 | 0 | 0 | 0 |
| 2008-01 | 0 | 0 | 113,637 | 3,895,361 | 113,637 | 744,542 |
| 2007-12 | 0 | 0 | 9,091 | 345,458 | 9,091 | 194,001 |
| 2007-11 | 0 | 0 | 9,000 | 337,590 | 9,000 | 146,969 |
| 2007-08 | 0 | 0 | 2,750 | 81,097 | 2,750 | 33,742 |
| 2007-06 | 0 | 0 | 51,000 | 1,725,199 | 54,467 | 364,099 |
| 2007-01 | 0 | 0 | 102,391 | 3,079,921 | 0 | 0 |
| 2006-12 | 0 | 0 | 750,000 | 22,559,999 | 0 | 0 |
| 2006-11 | 0 | 0 | 42,728 | 976,334 | 42,728 | 421,298 |
| 2006-10 | 0 | 0 | 81,205 | 1,612,975 | 0 | 0 |
| 2006-05 | 2,000 | 28,770 | 0 | 0 | 0 | 0 |
| 2006-04 | 1,000 | 10,240 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Omrix Biopharmaceuticals, Inc. (OMRI)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-03-31 | Mashiach Nissim (President and COO) | Purchase | 2,000 | 14.50 | 29,000 |
| 2008-03-26 | Romagnoli Philippe (Director) | Purchase | 7,800 | 13.59 | 106,002 |
| 2008-03-26 | Rakin Kevin (Director) | Purchase | 2,000 | 13.65 | 27,292 |
| 2008-03-20 | Taub Robert (Chief Executive Officer) | Purchase | 26,400 | 12.10 | 319,527 |
| 2008-03-20 | Romagnoli Philippe (Director) | Purchase | 8,250 | 12.02 | 99,204 |
| 2008-03-19 | Taub Robert (Chief Executive Officer) | Purchase | 53,600 | 12.31 | 659,665 |
| 2008-03-19 | Romagnoli Philippe (Director) | Purchase | 13,940 | 12.24 | 170,567 |
| 2008-03-18 | Droppert V. Marc (Executive Vice President) | Purchase | 4,000 | 12.48 | 49,919 |
| 2008-01-04 | Burshtine Michael (Other) | Sale | 32,665 | 34.00 | 1,110,610 |
| 2008-01-04 | Burshtine Michael (Other) | Option Exercise | 32,665 | 6.19 | 202,196 |
| 2008-01-03 | Burshtine Michael (Other) | Sale | 10,881 | 34.02 | 370,117 |
| 2008-01-03 | Burshtine Michael (Other) | Option Exercise | 10,881 | 9.97 | 108,483 |
| 2008-01-02 | Burshtine Michael (Other) | Sale | 70,091 | 34.45 | 2,414,634 |
| 2008-01-02 | Burshtine Michael (Other) | Option Exercise | 70,091 | 6.19 | 433,863 |
| 2007-12-11 | Mashiach Nissim (Senior VP, Operations) | Sale | 9,091 | 38.00 | 345,458 |
| 2007-12-11 | Mashiach Nissim (Senior VP, Operations) | Option Exercise | 9,091 | 21.34 | 194,001 |
| 2007-11-08 | Prado Nanci (General Counsel) | Sale | 9,000 | 37.51 | 337,590 |
| 2007-11-08 | Prado Nanci (General Counsel) | Option Exercise | 9,000 | 16.33 | 146,969 |
| 2007-08-13 | St Peter Steven (Director) | Sale | 2,750 | 29.49 | 81,097 |
| 2007-08-13 | St Peter Steven (Director) | Option Exercise | 2,750 | 12.27 | 33,742 |
| 2007-06-29 | Horowitz Bernard (Director) | Option Exercise | 2,750 | 12.27 | 33,742 |
| 2007-06-06 | Horowitz Bernard (Director) | Option Exercise | 2,717 | 10.00 | 27,170 |
| 2007-06-05 | Horowitz Bernard (Director) | Sale | 2,000 | 34.50 | 69,000 |
| 2007-06-04 | Price Fredric D (Director) | Sale | 49,000 | 33.80 | 1,656,199 |
| 2007-06-04 | Price Fredric D (Director) | Option Exercise | 49,000 | 6.19 | 303,187 |
| 2007-01-17 | Taub Robert (Pres., Chief Executive Officer) | Sale | 102,391 | 30.08 | 3,079,921 |
| 2006-12-20 | Taub Robert (Pres., Chief Executive Officer) | Sale | 682,606 | 30.08 | 20,532,788 |
| 2006-12-20 | Romagnoli Philippe (Vice President and Secretary) | Sale | 67,394 | 30.08 | 2,027,211 |
| 2006-11-09 | Mashiach Nissim (Senior VP, Operations) | Sale | 42,728 | 22.85 | 976,334 |
| 2006-11-09 | Mashiach Nissim (Senior VP, Operations) | Option Exercise | 42,728 | 9.86 | 421,298 |
| 2006-10-24 | Evnin Luke (10% Owner) | Sale | 21,402 | 19.76 | 422,828 |
| 2006-10-24 | Gadicke Ansbert (10% Owner) | Sale | 15,095 | 19.76 | 298,224 |
| 2006-10-23 | Evnin Luke (10% Owner) | Sale | 30,483 | 19.95 | 608,135 |
| 2006-10-23 | Gadicke Ansbert (10% Owner) | Sale | 14,225 | 19.95 | 283,788 |
| 2006-05-16 | Horowitz Bernard (Director) | Purchase | 1,000 | 14.20 | 14,200 |
| 2006-05-15 | Horowitz Bernard (Director) | Purchase | 1,000 | 14.57 | 14,570 |
| 2006-04-24 | Horowitz Bernard (Director) | Purchase | 1,000 | 10.24 | 10,240 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Omrix Biopharmaceuticals, Inc. (symbol OMRI,
CIK number 1349426) see
the Securities and Exchange Commission (SEC) website.
|
|
